Current gene therapy for stomach carcinoma

World Journal of Gastroenterology

Volumn 7, Issue 6, 2001, Pages 752-759

  Xu, C T ^a   Huang, L T ^a   Pan, B R ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BETA GALACTOSIDASE; CISPLATIN; COMPLEMENTARY RNA; CYTIDINE DEAMINASE; CYTOKINE; FLUCYTOSINE; FLUOROURACIL; INTERCELLULAR ADHESION MOLECULE 1; MAMMALIAN DEGENERIN G430F; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 5T4; MYC PROTEIN; SODIUM ION; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANTINEOPLASTIC ACTIVITY; BRAIN TUMOR; CLONING; DOSE RESPONSE; DRUG EFFICACY; DRUG SENSITIVITY; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENE TARGETING; GENE TECHNOLOGY; GENE THERAPY; GENE TRANSFER; HUMAN; IMMUNOMODULATION; LYMPH NODE METASTASIS; NONHUMAN; REVIEW; STOMACH CANCER; STOMACH CARCINOMA; SUICIDE GENE THERAPY; TUMOR SUPPRESSOR GENE;

EID: 0035687120     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v7.i6.752     Document Type: Review

References (112)

1. DNA methylation and folate metabolism in gastric cancer
2. A preliminary clinical report of 2LC reagent for early gastric cancer diagnosis
3. A model of gastric precancerous lesions for rats
4. The function of apoptosis and protein expression of bcl-2, p53 and C-myc in the development of gastric cancer
5. Cloning of gcys-18 overexpressed in Chinese gastric carcinoma and its clinical significance
6. CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia
7. Clinical trials in the gene therapy of arthritis
8. Evaluation of an intrathecal immune response in amyotrophic lateral sclerosis patients implanted with encapsulated genetically engineered xenogeneic cells
9. Adenoviral-mediated p53 gene transfer to non-small cell lung cancer through endobronchial injection
10. Induction of melanoma-associated antigen systemic immunity upon intratumoral delivery of interferon-gamma retroviral vector in melanoma patients
11. P21 gene expression as an indicator for the activity of adenovirus-p53 gene therapy in non-small cell lung cancer patients
12. A prospective phase II trial of ONYX-015 adenovirus and chemotherapy in recurrent squamous cell carcinoma of the head and neck (the Baylor experience)
13. Gene-modified PA1-STK cells home to tumor sites in patients with malignant pleural mesothelioma
14. Left ventricular electromechanical mapping to assess efficacy of phVEGF (165) gene transfer for therapeutic angiogenesis in chronic myocardial ischemia
15. Current status of gene therapy in gastroenterology
16. A cancer gene therapy approach utilizing an anti-erbB-2 single-chain antibody-encoding adenovirus (AD21): A phase I trial
17. Suppression of facilitative glucose transporter 1 mRNA can suppress tumor growth
18. Phase I study of adenoviral delivery of the HSV-tk gene and ganciclovir administration in patients with current malignant brain tumors
19. A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer
20. Biological activity and safety of adenoviral vector-expressed wild-type p53 after intratumoral injection in melanoma and breast cancer patients with p53-overexpressing tumors
21. Increased non-major histocompatibility complex-restricted lytic activity in melanoma patients vaccinated with cytokine gene-transfected autologous tumor cells
22. Repeat administration of DNA/ liposomes to the nasal epithelium of patients with cystic fibrosis
23. The relationship of traditional Chinese medicine and Helicobacter pylori infection, expression of oncogene and tumor suppresser genes in patients with gastric cancer and precancerous lessions
24. 4 lymph nodes excision in advanced gastric cancer
25. 2 and oligosaccharide protein in serum from patients with gastric carcinoma
26. Helicobacter pylori vacA genotypes and cagA status and their relationship to associated diseases
27. Progress of gastric cancer etiology: N-nitrosamides in the 1990s
28. Suppression of P-gp induced multiple drug resistance in a drug resistant gastric cancer cell line by overexpression of Fas
29. Fish sauce and gastric cancer: An ecological study in Fujian Province, China
30. Effects of tachyplesin on the morphology and ultrastructure of human gastric carcinoma cell line BGC-823
31. Replication-restricted vaccinia as a cytokine gene therapy vector in cancer: Persistent transgene expression despite antibody generation
32. Cellular and humoral immune responses to adenovirus and p53 protein antigens in patients following intratumoral injection of an adenovirus vector expressing wild-type. P53 (Ad-p53)
33. Transfection of nasal mucosa with a normal alpha1-antitrypsin gene in alpha1-antitrypsin-deficient subjects: Comparison with protein therapy
34. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease
35. Immunogenetic therapy of human melanoma utilizing autologous tumor cells transduced to secrete granulocyte-macrophage colony-stimulating factor
36. Cationic polymeric gene delivery of beta-glucuronidase for doxorubicin prodrug therapy
37. Multicolumn infusion of gene therapy cells into human brain tumors: Technical report
38. Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector
39. Therapeutic genes for cancer gene therapy
40. Treatment of progressive or recurrent pediatric malignant supratentorial brain tumors with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration
41. Interferon-alpha gene therapy in combination with CD80 transduction reduces tumorigenicity and growth of established tumor in poorly immunogenic tumor models
42. Gene therapy: Trials and tribulations
43. Developments in suicide genes for preclinical and clinical applications
44. Gene therapy: A molecular approach to cancer treatment
45. Gene therapy: Recent progress in the clinical oncology arena
46. Cancer gene therapy using a pro - apoptotic gene, caspase-3
47. Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer
48. Specifically targeted killing of carcinoembryonic antigen (CEA)-expressing cells by a retroviral vector displaying single-chain variable fragmented antibody to CEA and carrying the gene for inducible nitric oxide synthase
49. Molecular therapy with recombinant antisense c-myc adenovirus for human gastric carcinoma cells in vitro and in vivo
50. Isolation of a high affinity scFv from a monoclonal antibody recognising the oncofoetal antigen 5T4
51. Angiogenic interactions of vascular endothelial growth factor, of thymidine phosphorylase, and of p53 protein expression in locally advanced gastric cancer
52. A novel strategy for cancer therapy by mutated mammalian degenerin gene transfer
53. Study of primary leiomyosarcoma induced by MNNG in BALB/C nude mice
54. A study of preoperative methionine-depleting parenteral nutrition plus chemotherapy in gastric cancer patients
55. 121 in gastric carcinoma MGC803 cell line
56. A clinical and long-term follow-up study of peri-operative sequential triple therapy for gastric cancer
57. Helicobacter pylori infection and risk of gastric cancer in Changle County, Fujian Province, China
58. Antisense telomerase RNA induced human gastric cancer cell apoptosis
59. A study on arsenic trioxide inducing in vitro apoptosis of gastric cancer cell lines
60. Relationship between collagen IV expression and biological behavior of gastric cancer
61. Expression of the CagA gene of H. pylori and application of its product
62. The expression and clinical significance of CD44v in human gastric cancers
63. ICAM-1 (intercellular adhesion molecule-1) gene transfection inhibits lymph node metastasis by human gastri cancer cells
64. Potential applications of gene therapy in the patient with cancer
65. Transduction effect of antisense K-ras on malignant phenotypes in gastric cancer cells
66. Cre-loxP-mediated bax gene activation reduces growth rate and increase sensitivity to chemotherapeutic agents in human gastric cancer cells
67. A transgenic mouse line that develops early-onset invasive gastric carcinoma provides a model for carcinoembryonic antigen-targeted tumor therapy
68. Detection of telomerase activity and cytology in diagnosis of cardiac cancer
69. Detection of cancer cells in peripheral blood with nested RT-PCR and its significance in patients with gastric carcinomas
70. Effect of treatment of tumor-infiltrating lymphocytes on gastric cancer
71. Gastric cancer screening in 16 villages of Zhuanghe region: A mass screening report from a high risk area of stomach cancer in China
72. Determination of lipid peroxide and superoxide dismutase in blood and tissue of patients with gastrointestinal cancer
73. ATRA inhibits experimental liver metastasis of gastric cancer cells in nude mice
74. Relation between N-Nitrosos compound and gastric cancer - Establishment of a model system and research for human gastric cancer
75. Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease: Anesthetic management and results
76. Monitoring malignant melanoma with the S-100B tumour marker: Recent results
77. Thymidine kinase gene therapy for human malignant glioma, using replication-deficient retroviruses or adenoviruses
78. Adenoviral-mediated suicide gene therapy for ovarian cancer
79. Phase I clinical trial with IL-2-transfected xenogeneic cells administered in subcutaneous metastatic tumours: Clinical and immunological findings
80. Antibody-mediated endocytosis of G250 tumor-associated antigen allows targeted gene transfer to human renal cell carcinoma in vitro
81. Prostate cancer gene therapy: Outcome of basic research and clinical trials
82. Aspartoacylase gene transfer to the mammalian central nervous system with therapeutic implications for Canavan disease
83. Thymidine kinase gene therapy with concomitant topotecan chemotherapy for recurrent ovarian cancer
84. Osteocalcin-directed gene therapy for prostate-cancer bone metastasis
85. Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: Results of a phase I trial
86. Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma
87. Efficient retrovirus-mediated transfer of the multidrug resistance 1 gene into autologous human long-term repopulation hematopoietic stem cells
88. Ascorbic acid secretion in the human stomach and the effect of gastrin
89. Helicobacter pylori infection and gastrointestinal hormones: A review
90. Multiple genetic alterations and behavior of cellular biology in gastric cancer and other gastric mucosal lesions: H. pylori infection, histological types and staging
91. The therapeutic effects of recombinant adenovirus RA538 on human gastric carcinoma cells in vitro and in vivo
92. Early apoptosis in intestinal and diffuse gastric carcinomas
93. Observation of morphological changes and cytoplasmic movement in apoptosis process
94. Induction of apoptosis of lymphocytes in rat mucosal immune system
95. Transduction of Fas gene or bcl-2 antisense RNA sensitizes cultured drug resistant gastric cancer cells to chemotherapeutic drugs
96. Presence of Fas and bcl-2 proteins in BEL-7404 human hepatoma cells
97. Relationship between expression of apoptosis-related antigens in hepatocellular carcinoma and in situ end labeling
98. Expression and significance of proapoptotic gene Bax in gastric carcinoma
99. Apoptosis and its relationship with cell proliferation, p53, Waf1 p21, bcl-2 and c-myc in esophageal carcinogenesis studied with a high-risk population in northern China
100. Targeted gene delivery into alpha9beta1-integrin-displaying cells by a synthetic peptide
101. Hepatoma-specific gene therapy through retrovirus-mediated and targeted gene transfer using an adenovirus carrying the ecotropic receptor gene
102. Synergistic inhibition of tumor growth in a murine mammary adenocarcinoma model by combinational gene therapy using IL-12, pro-IL-18, and IL-1 beta converting enzyme cDNA
103. Enzyme prodrug gene therapy: Synergistic use of the herpes simplex virus-cellular thymidine kinase/ganciclovir system and thymidylate synthase inhibitors for the treatment of colon cancer
104. Imaging adenoviral-mediated herpes virus thymidine kinase gene transfer and expression in vivo
105. Distribution of recombinant adenovirus in the cerebrospinal fluid of nonhuman primates
106. In vivo expression of prostate-specific adenoviral vectors in a canine model
107. Selective gene delivery to head and neck cancer cells via an integrin targeted adenoviral vector
108. Cancer gene therapy with HSV-tk/GCV system depends on T-cell-mediated immune responses and causes apoptotic death of tumor cells in vivo
109. Regional versus systemic delivery of recombinant vaccinia virus as suicide gene therapy for murine liver metastases
110. Use of protamine to augment adenovirus-mediated cancer gene therapy
111. Abnormal drug accumulation in multidrug resistant gastric carcinoma cells
112. Expression and significance of p16 gene in gastric cancer and its precancerous lesions